Sales of Biogen Idec, Elan MS drug halted following death
Biogen Idec and Elan withdrew its new multiple sclerosis (MS) treatment Tysabri from the market after the death of a ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.